Factors associated with HPV vaccine hesitancy among college students: A cross-sectional survey based on 3Cs and structural equation model in China

References

• Rodriguez NM. Participatory innovation for human papillomavirus screening to accelerate the elimination of cervical cancer. Lancet Glob Health. 2021;9(5):582–9. doi:10.1016/S2214-109X(20)30522-2.
   Web of Science ®Google Scholar
• Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA-Cancer J Clin. 2021;71(3):209–49. doi:10.3322/caac.21660.
   PubMed Web of Science ®Google Scholar
• Soliman M, Oredein O, Dass CR. Update on safety and efficacy of HPV vaccines: focus on gardasil. Int J Mol Cell Med. 2021;10(2):101–113. doi:10.22088/IJMCM.BUMS.10.2.101.
   PubMed Web of Science ®Google Scholar
• Niu J, Pan S, Wei Y, Hong Z, Gu L, Di W, Qiu L. Epidemiology and analysis of potential risk factors of high-risk Human Papillomavirus (HPV) in Shanghai China: a cross-sectional one-year study in non-vaccinated women. J Med Virol. 2022;94(2):761–70. doi:10.1002/jmv.27453.
   PubMed Web of Science ®Google Scholar
• Damm O, Horn J, Mikolajczyk RT, Kretzschmar MEE, Kaufmann AM, Deleré Y, Ultsch B, Wichmann O, Krämer A, Greiner W. et al. Cost-effectiveness of human papillomavirus vaccination in Germany. Cost Effect Resour A. 2017;15(1):1–19. doi:10.1186/s12962-017-0080-9.
   PubMedGoogle Scholar
• Laprise JF, Chesson HW, Markowitz LE, Drolet M, Martin D, Bénard É, Brisson M. Effectiveness and cost-effectiveness of human papillomavirus vaccination through age 45 years in the United States. Ann Intern Med. 2020;172(1):22–9. doi:10.7326/M19-1182.
   PubMed Web of Science ®Google Scholar
• Tang CH, Cheng WF, Jiang JH, You SL, Huang L-W, Hsieh J-Y, Mukherjee P, Van Kriekinge G, Lee C. Cost-effectiveness analysis of human papillomavirus vaccination in adolescent girls in Taiwan. Asian Pac J Cancer P. 2019;20(5):1377. doi:10.31557/APJCP.2019.20.5.1377.
   PubMedGoogle Scholar
• Garland SM, Kjaer SK, Muñoz N, Block SL, Brown DR, DiNubile MJ, Lindsay BR, Kuter BJ, Perez G, Dominiak-Felden G. et al. Impact and effectiveness of the quadrivalent human papillomavirus vaccine: a systematic review of 10 years of real-world experience. Clin Infect Dis. 2016;63(4):519–527. doi:10.1093/cid/ciw354.
   PubMed Web of Science ®Google Scholar
• Wei L, Xie X, Liu J, Qiao Y, Zhao F, Wu T, Zhang J, Ma D, Kong B, Chen W. et al. Elimination of cervical cancer: challenges promoting the HPV vaccine in China. Indian J Gynecol Oncol. 2021;19(3):51. doi:10.1007/s40944-021-00536-6.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Immunization. 2022 Jun 15. https://www.who.int/topics/immunization/zh/.
   Google Scholar
• Thomas TL. Cancer prevention: HPV vaccination. Semin Oncol Nurs. 2016;32(3):273–80. WB Saunders. doi:10.1016/j.soncn.2016.05.007.
   PubMed Web of Science ®Google Scholar
• Santhanes D, Wong CP, Yap YY, San SP, Chaiyakunapruk N, Khan TM. Factors involved in Human Papillomavirus (HPV) vaccine hesitancy among women in the South-East Asian Region (SEAR) and Western Pacific Region (WPR): a scoping review. Hum Vaccin Immunother. 2018;14(1):124–33. doi:10.1080/21645515.2017.1381811.
   PubMed Web of Science ®Google Scholar
• Wilson SL, Wiysonge C. Social media and vaccine hesitancy. BMJ Glob Health. 2020;5(10):e004206. doi:10.1136/bmjgh-2020-004206.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Ten threats to global health in 2019. 2019. [accessed 2022 Jun 19]. https://www.who.int/emergencies/ten-threats-to-global-health-in-2019.
   Google Scholar
• Simms KT, Hanley SJB, Smith MA, Keane A, Canfell K. Impact of HPV vaccine hesitancy on cervical cancer in Japan: a modelling study. Lancet Glob Health. 2020;5(4):223–34. doi:10.1016/S2468-2667(20)30010-4.
   Google Scholar
• Tagliaferro J, Glauser J. Vaccine Hesitancy. Curr Emerg Hosp Med Rep. 2022;10(2):13–17. doi:10.1007/s40138-022-00243-2.
   PubMed Web of Science ®Google Scholar
• Siu JY, Fung TKF, Leung LH. Social and cultural construction processes involved in HPV vaccine hesitancy among Chinese women: a qualitative study. Int J Equity Health. 2019;18(1):1–18. doi:10.1186/s12939-019-1052-9.
   PubMed Web of Science ®Google Scholar
• Wang X, Du T, Shi X, Wu K. Awareness and knowledge about human papilloma virus infection among students at secondary occupational health school in China. Int J Env Res Pub He. 2021;18(12):6321. doi:10.3390/ijerph18126321.
   PubMed Web of Science ®Google Scholar
• Kessler R, Auwaerter P. Strategies to improve human papillomavirus (HPV) vaccination rates among college students. J Am Coll Health. 2021;71(7), 1–8. doi:10.1080/07448481.2021.1965146.
   Web of Science ®Google Scholar
• Marti M, de Cola M, MacDonald NE, Dumolard L, Duclos P. Assessments of global drivers of vaccine hesitancy in 2014—looking beyond safety concerns. PLoS One. 2017;12(3):e0172310. doi:10.1371/journal.pone.0172310.
   PubMed Web of Science ®Google Scholar
• Lai X, Li M, Hou Z, Zhang H, Wang J, Fang H. Factors associated with caregivers’ hesitancy to vaccinate children against influenza: a cross-sectional survey in China. Vaccine. 2022;40(29):3975–83. doi:10.1016/j.vaccine.2022.05.023.
   PubMed Web of Science ®Google Scholar
• Oduwole EO, Pienaar ED, Mahomed H, Wiysonge CS. Current tools available for investigating vaccine hesitancy: a scoping review protocol. BMJ Open. 2019;9(12):e033245. doi:10.1136/bmjopen-2019-033245.
   PubMed Web of Science ®Google Scholar
• Verger P, Botelho-Nevers E, Garrison A, Gagnon D, Gagneur A, Gagneux-Brunon A, Dubé E. Vaccine hesitancy in health-care providers in Western countries: a narrative review. Expert Rev Vaccines. 2022;(7), 1–19. doi:10.1080/14760584.2022.2056026.
   Web of Science ®Google Scholar
• Lau JTF, Wu AMS, Ma YL, Lau MMC. Associated factors of behavioral intention regarding childhood influenza vaccination among parents of ever-vaccinated and never-vaccinated 24-to 59-month-old children in Hong Kong. Asia-Pac J Public He. 2021;33(2–3):262–72. doi:10.1177/1010539520973098.
   PubMed Web of Science ®Google Scholar
• Han Y, Yin J, Zeng Y, Chu CI, Chiang YC, Fang Y. Determinants of parental intentions to vaccinate kindergarten children against seasonal influenza in Xiamen, China. J Prim Prev. 2019;40(3):325–42. doi:10.1007/s10935-019-00550-7.
   PubMed Web of Science ®Google Scholar
• Gao X, Li H, He W, Zeng W. COVID-19 vaccine hesitancy among medical students: the next COVID-19 challenge in Wuhan, China. Disaster Med Public. 2021;1–6. doi:10.1017/dmp.2021.291.
   Web of Science ®Google Scholar
• Zhou L, Wang J, Cheng P, Li Y, Liu G, Zhang X. HPV vaccine hesitancy among medical students in China: a multicenter survey. Front Public Health. 2022;10:92. doi:10.3389/fpubh.2022.774767.
   Web of Science ®Google Scholar
• Huang Y, Chen C, Wang L, Wu H, Chen T, Zhang L. HPV vaccine hesitancy and influencing factors among university students in China: a cross-sectional survey based on the 3Cs model. Int J Envir Res Pub Health. 2022;19(21):14025. doi:10.3390/ijerph192114025.
   PubMed Web of Science ®Google Scholar
• Szilagyi PG, Albertin CS, Gurfinkel D, Saville AW, Vangala S, Rice JD, Helmkamp L, Zimet GD, Valderrama R, Breck A. et al. Prevalence and characteristics of HPV vaccine hesitancy among parents of adolescents across the US. Vaccine. 2020;38(38):6027–6037. doi:10.1016/j.vaccine.2020.06.074.
   PubMed Web of Science ®Google Scholar
• Collier JE . Applied structural equation modelling using AMOS: basic to advanced techniques. 1st ed. New York: Routledge; 2020. doi:10.4324/9781003018414.
   Google Scholar
• Cvjetković S, Jeremić Stojković V, Piperac P, Djurdjević O, Bjegović-Mikanović V. Determinants of COVID-19 vaccine hesitancy: questionnaire development and validation. Cent Eur J Publ Heal. 2022;30(2):99–106. doi:10.21101/cejph.a7074.
   PubMed Web of Science ®Google Scholar
• Tostrud L, Thelen J, Palatnik A. Models of determinants of COVID-19 vaccine hesitancy in non-pregnant and pregnant population: review of current literature. Hum Vaccin Immunother. 2022;18(6):2138047. doi:10.1080/21645515.2022.2138047.
   PubMed Web of Science ®Google Scholar
• González-Block MÁ, Pelcastre-Villafuerte BE, Riva Knauth D, Fachel-Leal A, Comes Y, Crocco P, Noboa L, Rodríguez Zea B, Ruoti M, Díaz Portillo SP. et al. Influenza vaccination hesitancy in large urban centers in South America. Qualitative analysis of confidence, complacency and convenience across risk groups. PloS ONE. 2021;16(8):e0256040. doi:10.1371/journal.pone.0256040.
   PubMed Web of Science ®Google Scholar
• Devika R, Harikrishna M, Anjaneyulu M. Influence of psychological factors in mode choice decision making: a structural equation modelling approach. Transport Res Procedia. 2020;48:2821–30. doi:10.1016/j.trpro.2020.08.236.
   Google Scholar
• Wang J, Zhang Y, Long S, Fu X, Zhang X, Zhao S, Xiu S, Wang X, Lu B, Jin H. et al. Non-EPI vaccine hesitancy among Chinese adults: a cross-sectional study. Vaccines. 2021;9(7):772. doi:10.3390/vaccines9070772.
   PubMed Web of Science ®Google Scholar
• Ran H, Chen Y, Gao J, Guo H, Peng S. Low awareness of HPV infection and willingness of HPV vaccination among Chinese male college students in the east of China. Front Public Health. 2022;10:971707. doi:10.3389/fpubh.2022.971707.
   PubMed Web of Science ®Google Scholar
• Dai Z, Si M, Su X, Wang W, Zhang X, Gu X, Ma L, Li J, Zhang S, Ren Z. et al. Willingness to human papillomavirus (HPV) vaccination and influencing factors among male and female university students in China. J Med Virol. 2022;94(6):2776–86. doi:10.1002/jmv.27478.
   PubMed Web of Science ®Google Scholar
• Zhang F, Li D. Multiple linear regression-structural equation modeling based development of the integrated model of perceived neighborhood environment and quality of life of community-dwelling older adults: a cross-sectional study in Nanjing, China. Int J Env Res Pub He. 2019;16(24):4933. doi:10.3390/ijerph16244933.
   PubMed Web of Science ®Google Scholar
• Wirayuda AAB, Jaju S, Alsaidi Y, Chan MF. A structural equation model to explore sociodemographic, macroeconomic, and health factors affecting life expectancy in Oman. Pan Afr Med J. 2022;41:75. doi:10.11604/pamj.2022.41.75.28488.
   PubMed Web of Science ®Google Scholar
• Han G, Son H. Environmental factors affecting mothers’ decision-making about the HPV vaccination for their daughters. Hum Vacc Immunother. 2021;17(11):4412–7. doi:10.1080/21645515.2021.1965808.
   PubMed Web of Science ®Google Scholar
• You D, Han L, Li L, Hu J, D Zimet G, Alias H, Danaee M, Cai L, Zeng F, Wong LP. Human papillomavirus (HPV) vaccine uptake and the Willingness to Receive the HPV vaccination among female college students in China: a multicenter study. Vaccines (Basel). 2020;8(1):31. Published 2020 Jan 16. doi:10.3390/vaccines8010031.
   PubMed Web of Science ®Google Scholar
• Thompson EL, Vamos CA, Vázquez-Otero C, Logan R, Griner S, Daley EM. Trends and predictors of HPV vaccination among US college women and men. Prev Med. 2016;86:92–8. doi:10.1016/j.ypmed.2016.02.003.
   PubMed Web of Science ®Google Scholar
• Hu S, Xu X, Zhang Y, Liu Y, Yang C, Wang Y, Wang Y, Yu Y, Hong Y, Zhang X. et al. A nationwide post-marketing survey of knowledge, attitude and practice toward human papillomavirus vaccine in general population: implications for vaccine roll-out in mainland China. Vaccine. 2021;39(1):35–44. doi:10.1016/j.vaccine.2020.11.029.
   PubMed Web of Science ®Google Scholar
• Chau JPC, Lo SHS, Butt L, Lee VW, Lui GC, Lau AY. User engagement on a novel educational health intervention aimed at increasing HPV vaccine uptake in Hong Kong: a qualitative study. J Cancer Educ. 2023;38(3):772–80. doi:10.1007/s13187-022-02183-7.
   PubMed Web of Science ®Google Scholar
• Shapiro GK, Tatar O, Dube E, Amsel R, Knauper B, Naz A, Perez S, Rosberger Z. The vaccine hesitancy scale: psychometric properties and validation. Vaccine. 2018;36(5):660–7. doi:10.1016/j.vaccine.2017.12.043.
   PubMed Web of Science ®Google Scholar
• Hansen PR, Schmidtblaicher M, Brewer NT. Resilience of HPV vaccine uptake in Denmark: decline and recovery. Vaccine. 2020;38(7):1842–1848. doi:10.1016/j.vaccine.2019.12.019.
   PubMed Web of Science ®Google Scholar
• Chen L, Zhang Y, Young R, Wu X, Zhu G. Effects of vaccine-related conspiracy theories on Chinese young adults’ perceptions of the HPV vaccine: an experimental study. Health Commun. 2021;36(11):1343–53. doi:10.1080/10410236.2020.1751384.
   PubMed Web of Science ®Google Scholar
• Dubé E, Bettinger JA, Fisher WA, Naus M, Mahmud SM, Hilderman T. Improving Vaccination Rates: Vaccine acceptance, hesitancy and refusal in Canada: challenges and potential approaches. Can Commun Dis Rep. 2016;42(12):246. doi:10.14745/ccdr.v42i12a02.
   PubMedGoogle Scholar
• Stahl JP, Cohen R, Denis F, Gaudelus J, Martinot A, Lery T, Lepetit H. The impact of the web and social networks on vaccination. New challenges and opportunities offered to fight against vaccine hesitancy. Méd Mal Infect. 2016;46(3):117–22. doi:10.1016/j.medmal.2016.02.002.
   PubMed Web of Science ®Google Scholar
• Ruiz JB, Bell RA. Predictors of intention to vaccinate against COVID-19: results of a nationwide survey. Vaccine. 2021;39(7):1080–1086. doi:10.1016/j.vaccine.2021.01.010.
   PubMed Web of Science ®Google Scholar
• Chen Q, Zhou T, Zhong X. Factors related to HPV vaccination intention among MSM in China: a bayesian network model. Int J Envir Res Pub Health. 2022;19(23):15532. doi:10.3390/ijerph192315532.
   PubMed Web of Science ®Google Scholar